Skip to content
★ Sign in to follow
LR

Lisa Rojkjaer

Directeur Médical
Viracta Therapeutics, Inc.Rigel Pharmaceuticals Inc
Total declarations
18
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€47k

Latest filing published 19 Feb 2026 for RIGEL PHARMACEUTICALS INC.

Filing timeline

BuySale
Lisa Rojkjaer

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

Lisa Rojkjaer: trading record in brief

Filings by Lisa Rojkjaer span 2 companies, the busiest being Viracta Therapeutics, Inc. and Rigel Pharmaceuticals Inc. In total, 18 filings cover trades dated from 11 May 2021 to 17 February 2026.

The open-market record consists of 7 sales worth €47k, with no purchase. Besides market trades, the filings include 3 share grants and 8 option exercises.

The newest entry dates from 19 February 2026: a share grant, in Rigel Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Lisa Rojkjaer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations